Smith & Nephew Publishes Meta-Analysis Suggesting PICO's Wound Therapy Reduces Surgical Site Infections
Smith & Nephew's meta-analysis of 16 peer-reviewed publications shows prophylactic application of the company's PICO Negative Pressure Wound Therapy System reduces surgical site infections by 58% and wound rupturing along the surgical incision by 26%, while cutting the average hospital stay by a half day.
You may also be interested in...
The National Institute for Health and Care Excellence recommends that UK’s National Health Service adopt Smith & Nephew’s PICO negative wood dressings as an option for closed surgical incisions in high-risk patients.
UK medical device multinational Smith & Nephew is to boost its advanced wound care division with the acquisition of BlueSky Medical, a privately-held, US company operating in the $1.2bn negative pressure wound therapy (NPWT) market.
NWW: Studies Back Nevro Pain Treatment, FTC Blesses Resonetics Nitinol Deal, Genetic Test Identifies Best RDN Patients
This week, studies supported Nevro’s spinal cord stimulation therapy and a VRx system that helps reduce pain; the American Medical Association found inconsistent insurance coverage of digital therapeutics; and Geneticure announced a cheek-swab test to identify which patients are most likely to benefit from renal denervation.